Exploring Functional Redundancy in the Immunoglobulin μ Heavy-Chain Gene Enhancer

REFERENCES

• Bain, G., E. C. R. Maandag, D. J. Izon, D. Amsen, A. M. Kruisbeek, B. C. Weintraub, I. Krop, M. S. Schlissel, A. J. Feeney, M. van Roon, M. van der Valk, H. P. J. te Riele, A. Berns, and C. Murre 1994. E2A proteins are required for proper B cell development and initiation of immunoglobulin gene rearrangements. Cell 79: 885–892.
   PubMed Web of Science ®Google Scholar
• Brass, A. L., E. Kehrli, C. F. Eisenbeis, U. Storb, and H. Singh 1996. Pip, a lymphoid-restricted IRF, contains a regulatory domain that is important for autoinhibition and ternary complex formation with the Ets factor PU.1. Genes Dev. 10: 2335–2347.
   PubMed Web of Science ®Google Scholar
• Carter, R. S., P. Ordentlich, and T. Kadesch 1997. Selective utilization of basic helix-loop-helix-leucine-zipper proteins at the immunoglobulin heavy-chain enhancer. Mol. Cell. Biol. 17: 18–23.
   PubMedGoogle Scholar
• Dang, W., X.-H. Sun, and R. Sen 1998. ETS-mediated cooperation between basic helix-loop-helix motifs of the immunoglobulin μ heavy-chain gene enhancer. Mol. Cell. Biol. 18: 1477–1488.
   PubMedGoogle Scholar
• Eisenbeis, C. F., H. Singh, and U. Storb 1995. Pip, a novel IRF family member, is a lymphoid-specific, PU.1-dependent transcriptional activator. Genes Dev. 9: 1377–1387.
   PubMed Web of Science ®Google Scholar
• Ephrussi, A., G. M. Church, S. Tonegawa, and W. Gilbert 1985. B lineage-specific interactions of an immunoglobulin enhancer with cellular factors in vivo. Science 227: 134–140.
   PubMed Web of Science ®Google Scholar
• Erman, B., M. Cortes, B. S. Nikolajczyk, N. A. Speck, and R. Sen 1998. ETS-core binding factor: a common composite motif in antigen receptor gene enhancers. Mol. Cell. Biol. 18: 1322–1330.
   PubMedGoogle Scholar
• Erman, B., and R. Sen 1996. Context dependent transactivation domains activate the immunoglobulin μ heavy chain gene enhancer. EMBO J. 15: 4665–4675.
   PubMed Web of Science ®Google Scholar
• Ernst, P., and S. T. Smale 1995. Combinatorial regulation of transcription II: the immunoglobulin μ heavy chain gene. Immunity 2: 427–438.
   PubMedGoogle Scholar
• Harada, H., K. Willison, J. Sakakibara, M. Miyamoto, and T. Fujita 1990. Absence of the type I IFN system in EC cells: transcriptional activator (IRF-1) and repressor (IRF-2) genes are developmentally regulated. Cell 63: 303–312.
   PubMed Web of Science ®Google Scholar
• Jenuwein, T., W. C. Forrester, L. A. Fernandez-Herrero, G. Laible, M. Dull, and R. Grosschedl 1997. Extension of chromatin accessibility by nuclear matrix attachment regions. Nature 385: 269–272.
   PubMedGoogle Scholar
• Kadesch, T., P. Zervos, and D. Ruezinsky 1986. Functional analysis of the murine IgH enhancer: evidence for negative control of cell-type specificity. Nucleic Acids Res. 14: 8209–8221.
   PubMed Web of Science ®Google Scholar
• Kiledjian, M., L.-K. Su, and T. Kadesch 1988. Identification and characterization of two functional domains within the murine heavy-chain enhancer. Mol. Cell. Biol. 8: 145–152.
   PubMedGoogle Scholar
• Libermann, T. W., and D. Baltimore 1990. Transcriptional regulation of immunoglobulin gene expression. Mol. Aspects Cell. Regul. 6: 399–421.
   Google Scholar
• Matsuyama, T., T. Kimura, M. Kitagawa, K. Pfeffer, T. Kawakami, N. Watanabe, T. M. Kundig, A. Wakeham, J. Potter, and C. L. Furlonger 1993. Targeted disruption of IRF-1 and IRF-2 results in abnormal type 1 IFN gene induction and aberrant lymphocyte development. Cell 75: 83–97.
   PubMed Web of Science ®Google Scholar
• Miyamoto, M., T. Fujita, Y. Kimura, M. Maruyama, H. Harada, Y. Sudo, T. Miyata, and T. Taniguchi 1988. Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-b gene regulatory elements. Cell 54: 903–913.
   PubMed Web of Science ®Google Scholar
• Murre, C., C. S. McCaw, and D. Baltimore 1989. A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, Myo D and myc proteins. Cell 50: 777–783.
   Google Scholar
• Nelsen, B., T. Kadesch, and R. Sen 1990. Complex regulation of the immunoglobulin μ heavy-chain gene enhancer: μB, a new determinant of enhancer function. Mol. Cell. Biol. 10: 3145–3154.
   PubMedGoogle Scholar
• Nelsen, B., and R. Sen 1992. Regulation of immunoglobulin gene transcription. Int. Rev. Cytol. 133: 121–149.
   PubMedGoogle Scholar
• Nelsen, B., G. Tian, B. Erman, J. Gregoire, R. Maki, B. Graves, and R. Sen 1993. Regulation of lymphoid-specific immunoglobulin μ heavy chain gene enhancer by ETS-domain proteins. Science 261: 82–86.
   PubMed Web of Science ®Google Scholar
• Nikolajczyk, B., B. Nelsen, and R. Sen 1996. Precise alignment of sites required for μ enhancer activation in B cells. Mol. Cell. Biol. 16: 4544–4554.
   PubMedGoogle Scholar
• Nikolajczyk, B. S., M. Cortes, R. Feinman, and R. Sen 1997. Combinatorial determinants of tissue-specific transcription in B cells and macrophages. Mol. Cell. Biol. 17: 3527–3535.
   PubMedGoogle Scholar
• Park, K., and M. L. Atchison 1991. Isolation of a candidate repressor/activator, NF-E1 (YY1, delta), that binds to the immunoglobulin kappa 3′ enhancer and the immunoglobulin heavy-chain μE1 site. Proc. Natl. Acad. Sci. USA 88: 9804–9808.
   PubMed Web of Science ®Google Scholar
• Rao, E., W. Dang, G. Tian, and R. Sen 1997. A three protein-DNA complex on a B cell-specific domain of the immunoglobulin μ heavy chain gene enhancer. J. Biol. Chem. 272: 6722–6732.
   PubMed Web of Science ®Google Scholar
• Sun, X., and D. Baltimore 1991. An inhibitory domain of E12 transcription prevents DNA binding in E12 homodimers but not in E12 heterodimers. Cell 64: 459–470.
   PubMed Web of Science ®Google Scholar
• Tanaka, N., T. Kawakami, and T. Taniguchi 1993. Recognition DNA sequences of interferon regulatory factor 1 (IRF-1) and IRF-2, regulators of cell growth and the interferon system. Mol. Cell. Biol. 13: 4531–4538.
   PubMed Web of Science ®Google Scholar
• Zhuang, Y., P. Soriano, and H. Weintraub 1994. The helix-loop-helix gene E2A is required for B cell formation. Cell 79: 875–884.
   PubMedGoogle Scholar